|
|
Volumn 65, Issue , 2011, Pages 734-751
|
|
[Dacarbazine, a chemotherapeutic against metastatic melanoma and a reference drug for new treatment modalities].;Dakarbazyna jako lek przeciwczerniakowy i referencyjny dla nowych programów terapeutycznych.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
DACARBAZINE;
DRUG DERIVATIVE;
INDOLE DERIVATIVE;
IPILIMUMAB;
MONOCLONAL ANTIBODY;
SULFONAMIDE;
TEMOZOLOMIDE;
VEMURAFENIB;
CHEMISTRY;
DNA DAMAGE;
DRUG EFFECT;
HUMAN;
IMMUNOTHERAPY;
MELANOMA;
METHODOLOGY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS, ALKYLATING;
DACARBAZINE;
DNA DAMAGE;
HUMANS;
IMMUNOTHERAPY;
INDOLES;
MELANOMA;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SULFONAMIDES;
|
|
EID: 84861420717
PISSN: None
EISSN: 17322693
Source Type: Journal
DOI: 10.5604/17322693.966832 Document Type: Review |
|
Times cited : (9)
|
|
References (0)
|
